Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy.

scientific article published in January 2017

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.14694/EDBK_174930
P698PubMed publication ID28561661

P50authorPaul LoriganQ32649737
P2093author name stringAhmad A Tarhini
Sancy Leachman
P304page(s)651-660
P577publication date2017-01-01
P1433published inAmerican Society of Clinical Oncology educational book / ASCOQ26842316
P1476titleOperable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy.
P478volume37

Reverse relations

cites work (P2860)
Q47792677A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma
Q57797941Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Search more.